Satoru Sakuragi
Overview
Explore the profile of Satoru Sakuragi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
596
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Naito T, Nakamura K, Abe Y, Watanabe H, Sakuragi S, Katayama Y, et al.
ESC Heart Fail
. 2025 Jan;
10(3):1896-1906.
PMID: 39868751
Aims: Heart failure with preserved ejection fraction (HFpEF), which is caused by wide various conditions, has become a major public health problem. Transthyretin amyloid cardiomyopathy (ATTR-CM), which is thought to...
2.
Iwasaki K, Miyoshi T, Urabe C, Sakuragi S, Kawai Y, Fuke S, et al.
J Clin Med
. 2024 Aug;
13(15).
PMID: 39124652
Indoxyl sulfate, a uremic toxin, is associated with mortality and cardiovascular events in patients with chronic kidney disease (CKD). This study aimed to evaluate the prognostic implications of serum indoxyl...
3.
Nakashima M, Miyoshi T, Tanakaya M, Saito T, Katayama Y, Sakuragi S, et al.
Heart Vessels
. 2023 Apr;
38(9):1181-1189.
PMID: 37087702
The fibrosis-4 index (FIB4), a liver fibrosis maker, has been shown to be associated with the prognosis in patients with severe isolated tricuspid regurgitation (TR). Recent study showed that the...
4.
Ejiri K, Miyoshi T, Kihara H, Hata Y, Nagano T, Takaishi A, et al.
Sci Rep
. 2022 Sep;
12(1):15449.
PMID: 36104378
Sodium-glucose cotransporter 2 inhibitors could reduce cardiovascular events in patients with heart failure irrespective of diabetes status. In this prespecified sub-analysis of randomised-controlled trial, we investigated the efficacy of luseogliflozin...
5.
Nakashima M, Tanakaya M, Miyoshi T, Saito T, Katayama Y, Sakuragi S, et al.
Circ J
. 2022 Aug;
86(11):1777-1784.
PMID: 35922937
Background: The fibrosis-4 (FIB-4) index is used to evaluate liver disease patients. It can also be used to evaluate the prognosis for heart disease patients; however, its ability to determine...
6.
Nakashima M, Miyoshi T, Ejiri K, Kihara H, Hata Y, Nagano T, et al.
ESC Heart Fail
. 2022 Mar;
9(1):712-720.
PMID: 35267246
Aims: Sodium glucose co-transporter 2 inhibitors have diuretic effects in both patients with glycosuria and with natriuresis. We sought to assess the effect of luseogliflozin on estimated plasma volume (ePV)...
7.
Nakashima M, Sakuragi S, Miyoshi T, Takayama S, Kawaguchi T, Kodera N, et al.
ESC Heart Fail
. 2021 Mar;
8(3):2240-2247.
PMID: 33760403
Aims: Fibrosis-4 index (FIB-4 index), calculated by age, aspartate aminotransferase, alanine aminotransferase, and platelet count, is a simple marker to evaluate liver fibrosis and is associated with right-sided heart failure....
8.
Ejiri K, Miyoshi T, Kihara H, Hata Y, Nagano T, Takaishi A, et al.
J Am Heart Assoc
. 2020 Aug;
9(16):e015103.
PMID: 32805185
Background Effects of sodium-glucose cotransporter 2 inhibitors on reducing hospitalization for heart failure have been reported in randomized controlled trials, but their effects on patients with heart failure with preserved...
9.
Wada T, Sakuragi S, Saito T, Kawaguchi T, Kodera N, Iida T, et al.
J Hypertens
. 2020 May;
38(6):1174-1182.
PMID: 32371808
Objectives: The current study was performed to determine whether pulmonary vein isolation (PVI) improves nocturnal hypertension in patients with paroxysmal atrial fibrillation (PAF). Background: Abnormal night-time blood pressure (BP) fluctuation...
10.
Ejiri K, Miyoshi T, Nakamura K, Sakuragi S, Munemasa M, Namba S, et al.
BMJ Open
. 2019 Apr;
9(3):e026590.
PMID: 30928954
Introduction: Type 2 diabetes mellitus (T2DM) is a strong risk factor for coronary artery disease and heart failure, particularly heart failure with preserved ejection fraction (HFpEF). The aim of the...